Get your news from a source that’s not owned and controlled by oligarchs. Sign up for the free Mother Jones Daily.


I got back my final lab results today. We were mainly looking for two things. First, the volume of the antibody that corresponds to the particular type of blood plasma cell that had become cancerous. In my case, that’s the IgG antibody, and over the course of the chemotherapy its volume has fallen from 6200 to 1580. This puts it—barely!—within the normal range. Second, the level of a protein marker that tells us what percentage of my plasma cells are healthy vs. cancerous. This has gone down from 4.2 to 1.18. Ideally I think it would be closer to zero than that, but it’s still a pretty good number.

Bottom line: the first stage of my chemotherapy has been successful and is now over. Hooray! The side effects are going to linger for a while, but hopefully not for more than a month or so. At that point, I’ll be ready for stage 2, which is an autologous stem cell transplant—that is, a procedure in which they draw out stem cells from my blood and then transplant them back into my body later. You can google the gory details if you really want them.

That will all happen in about a month or so, and will probably put me out of commission for a couple of weeks. In the meantime, I get several weeks of recovery time along with a whole bunch of pre-op workups. Should be loads of fun.

But the important thing is that stage 1 is over and I’m basically in remission. I’m now crossing my fingers and hoping that stage 2 is equally successful.

DECEMBER IS MAKE OR BREAK

A full one-third of our annual fundraising comes in this month alone. That’s risky, because a strong December means our newsroom is on the beat and reporting at full strength—but a weak one means budget cuts and hard choices ahead.

With only days left until December 31, we've raised about half of our $400,000 goal—but we need a huge surge in reader support to close the remaining gap. Whether you've given before or this is your first time, your contribution right now matters.

Managing an independent, nonprofit newsroom is staggeringly hard. There’s no cushion in our budget—no backup revenue, no corporate safety net. We can’t afford to fall short, and we can’t rely on corporations or deep-pocketed interests to fund the fierce, investigative journalism Mother Jones exists to do. That’s why we need you right now. Please chip in to help close the gap.

DECEMBER IS MAKE OR BREAK

A full one-third of our annual fundraising comes in this month alone. That’s risky, because a strong December means our newsroom is on the beat and reporting at full strength—but a weak one means budget cuts and hard choices ahead.

With only days left until December 31, we've raised about half of our $400,000 goal—but we need a huge surge in reader support to close the remaining gap. Whether you've given before or this is your first time, your contribution right now matters.

Managing an independent, nonprofit newsroom is staggeringly hard. There’s no cushion in our budget—no backup revenue, no corporate safety net. We can’t afford to fall short, and we can’t rely on corporations or deep-pocketed interests to fund the fierce, investigative journalism Mother Jones exists to do. That’s why we need you right now. Please chip in to help close the gap.

We Recommend

Latest

Sign up for our free newsletter

Subscribe to the Mother Jones Daily to have our top stories delivered directly to your inbox.

Get our award-winning magazine

Save big on a full year of investigations, ideas, and insights.

Subscribe

Support our journalism

Help Mother Jones' reporters dig deep with a tax-deductible donation.

Donate